Woodline Partners’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
ACM
AIC
Woodline Partners's ABEO Position: Q3 2026 in Review
Woodline Partners opened a new position in Abeona Therapeutics (ABEO) in Q3 2026: 551,837 shares worth $2.9M. The stake represents 0.01% of the portfolio and ranks #821 among its holdings. This is a return to the name: Woodline Partners previously reported a position in ABEO as recently as Q3 2020.
Woodline Partners first reported a position in ABEO in Q4 2019 and has held it in 5 quarters since. The position peaked at $4.1M in Q2 2020. 114 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.
- Woodline Partners held 551,837 shares of Abeona Therapeutics worth $2.9M as of Q3 2026.
- Abeona Therapeutics was a new Woodline Partners position in Q3 2026.
- Abeona Therapeutics made up 0.01% of Woodline Partners's portfolio in Q3 2026, its #821 holding.
- Woodline Partners first reported a position in Abeona Therapeutics in Q4 2019 and has held it in 5 quarters since.
- Woodline Partners's Abeona Therapeutics position peaked at $4.1M in Q2 2020.
- 114 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.
Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.